In this work, the capability of primary, monocyte-derived dendritic cells (DCs) to uptake iron oxide magnetic nanoparticles (MNPs) is assessed and a strategy to induce selective cell death in these MNP-loaded DCs using external alternating magnetic fields (AMFs) is reported. No significant decrease in the cell viability of MNP-loaded DCs, compared to the control samples, was observed after five days of culture. The amount of MNPs incorporated into the cytoplasm was measured by magnetometry, which confirmed that 1 to 5 pg of the particles were uploaded per cell. The intracellular distribution of these MNPs, assessed by transmission electron microscopy, was found to be primarily inside the endosomic structures. These cells were then subjected to an AMF for 30 min, and the viability of the blank DCs (i.e., without MNPs), which were used as control samples, remained essentially unaffected. However, a remarkable decrease of viability from approximately 90% to 2-5% of DCs previously loaded with MNPs was observed after the same 30 min exposure to an AMF. The same results were obtained using MNPs having either positive (NH 2 + ) or negative (COOH -) surface functional groups. In spite of the massive cell death induced by application of AMF to MNP-loaded DCs, the amount of incorporated magnetic particles did not raise the temperature of the cell culture. Clear morphological changes at the cell structure after magnetic field application were observed using scanning electron microscopy. Therefore, local damage produced by the MNPs could be the main mechanism for the selective cell death of MNP-loaded DCs under an AMF. Based on the ability of these cells to evade the reticuloendothelial system, these complexes combined with an AMF should be considered as a potentially powerful tool for tumour therapy.
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Introduction
The increasing synergy between biomedicine and nanoscience has been applied to the use of magnetic nanoparticles (MNPs) in routine laboratory and clinical protocols, such as cell sorting, DNA separation, magnetic resonance imaging (MRI) and gene therapy. [1, 2] Applications of MNPs currently in preclinical stages include the cell-targeted delivery of anticancer agents and molecular diagnosis. [3, 4] Recently, magnetic hyperthermia strategies passed preclinical trial stages and received regulatory approval as a clinical protocol for thermotherapy. [5] Thus, with proper control of size and surface functionalisation, magnetic nanoparticles could become multifunctional intracellular agents for MRI, drug carriers and/or heat generators for hyperthermia. [6] Loading MNPs with anticancer drugs and targeting to specific tumour sites is a promising strategy for the detection and elimination of neoplastic tissue, even at the single-cell level. However, a major obstacle for this approach is that the reticuloendothelial system (RES) detects and phagocytoses MNPs, preventing their targeting and therapeutic action. [7] Attempts to overcome this difficulty (i.e., to evade the RES) have been made through the functionalisation of MNPs to mimic biologic entities already present in the blood system, resulting in the generation of 'stealth' carriers. [8] Eukaryotic cells can easily be 'targeted' in vitro with MNPs of different sizes.
Different mechanisms have been reported for the detection and/or uptake of inorganic nanoparticles by cells, depending on the type of core material and surface coating of the particles used. The general consensus is that the mechanisms involved in particle incorporation are strongly dependent on the cell type. [9] Dendritic cells (DCs) are the most important antigen-presenting cells, as they have a key role in the first steps of most immune responses. [10] Therefore, DCs are good candidates as therapeutic tools for immune diseases and malignant neoplasms.
DCs are derived from bone marrow precursors and migrate to non-lymphoid tissues where they differentiate into dendritic cells. [11] As antigen-presenting cells, DCs are active at the membrane level and are thus good candidates to incorporate MNPs.
Indeed, previously published reports have demonstrated that DCs can incorporate
peptides, viral RNA, [12] bacterial DNA [13] and other molecules. [14] The uptake of antigens by DCs may occur by different processes, such as macropinocytosis, phagocytosis or receptor-mediated endocytosis [15] ; more recently, the ability of DCs to incorporate several types of solid particles within a broad size range has also been described [16] .
In the present work, the first results for a new strategy are demonstrated, based on the use of dendritic cells as natural carriers of magnetic nanoparticles. This investigation had two major goals: a) to study the inclusion and toxicity of magnetic nanoparticles in dendritic cells and b) to induce cell death by applying a time-varying magnetic field to the MNP-loaded DCs. The reason for using DCs as carriers of MNPs was to mimic biological units and to elude the immune response of the body. The advantage of using this strategy is that the cargo of the DCs could be designed to be either 'nude' magnetic MNPs for hyperthermia therapy or functionalised MNPs with specific drugs that could be released by the application of alternating magnetic fields (AMFs).
Materials and methods

Magnetic nanoparticles
A set of 18 different types of commercially available magnetic colloids (Micromod GmbH, Germany) [17] having different hydrodynamic sizes and surface functional groups was tested with respect to absorption efficiency (see Figure S1 The magnetic characterisation of colloids and cell cultures was performed in a commercial SQUID magnetometer (Quantum Design MPMS-XL) through static measurements as a function of field and temperature. Pure colloids were measured as is (i.e., in the liquid phase) after being conditioned in sealed sample holders with 200-µL capacity. Magnetisation data were collected in applied magnetic fields up to 5 T at temperatures between 5 K and 250 K to avoid the melting of the frozen liquid carrier.
To determine the magnetic behaviour at room temperature, hysteresis loops M(H)
were performed at T= 295 K in samples previously dried at room temperature. The same protocol was used for magnetic measurements in DC cultures.
Dendritic cell differentiation from PBMCs
Peripheral blood mononuclear cells (PBMCs) were isolated from normal blood by a density gradient (Ficoll Histopaque-1077, Sigma). Cells were washed twice with PBS and then centrifuged for 10 minutes at 800 rpm to avoid platelet contamination. 
Specific power absorption experiments
The specific power absorption (SPA) of the pure colloids was measured with a commercial ac field applicator (model DM100 from nB nanoscale Biomagnetics, Spain) at f = 260 kHz and field amplitudes from 0 to 16 mT; the applicator was equipped with an adiabatic sample space (~ 0.5 ml) for measurements in the liquid phase. For in vitro magnetic hyperthermia experiments, DCs cultured as described above were collected and seeded onto a 6-well plate at 10 6 cells/ml. COOH(MNP)-and NH2(MNP)+ nanoparticle suspensions (1% wt) were each added into two wells at a concentration of 50 µg MNP/ml medium. Two wells, each containing 10 6 cells/ml without nanoparticles, were used as a control. Cells were cultured overnight at 37ºC.
The next day, cells were collected from each well and washed four times with fresh medium to remove the MNPs that were not incorporated. Cells were counted and resuspended in 500 μl of the medium.
Figure 1: Schematic representation of the '2x2' experiment: (a) DCs with neither MNP uptake nor magnetic field application. (b) DCs uploaded with MNPs but without field application, (c) DCs without MNPs for magnetic field application, and (d) DCs with MNPs and the application of magnetic fields.
Each experiment consisted of four samples of cultured DCs, as illustrated in the medium was measured as described elsewhere. [19] After the field exposure, cell viability was measured in the four samples using Trypan blue and FACS (annexinpropidium iodide) protocols, as previously described.
Morphological analysis by scanning electron microscopy (SEM)
We investigated the possible effects of the alternating magnetic fields on cell morphology using scanning electron microscopy (SEM) The SPA values for the different types of commercial MNPs tested varied from 18 to 36.6 W/g ( Figure S1 in the supporting material). The SPA is known to depend strongly on the average particle size, size dispersion, particle interactions (through magnetic dipolar interactions) and the hydrodynamic diameter. [20, 21] There is usually a narrow size window where the SPA is maximised; this window is centred at some value that depends on magnetic parameters such as saturation magnetisation and magnetic anisotropy of the core material. Because the purpose of this study was to induce cell death with a minimum amount of MNPs, the two samples having a) the Table I . into endothelial cells when cultured in the presence of angiogenic growth factors [25] or tumour-conditioned media. [26] When DCs are stimulated by antigens and consequently reach a mature state, they lose their multipotency to differentiate into other types of cell. [27, 28] Therefore, giving the immature phenotype sufficient time for the DCs to reach the desired organ is essential for any potential therapeutic application. 
Results and discussion
Magnetic nanoparticles
Viability of DCs cultured with MNPs
The cytotoxicity produced by MNPs was another obstacle that needed to be overcome for biomedical applications. Therefore, the first step to evaluate the actual potential of this strategy was to determine whether DCs could incorporate this type of MNPs without affecting the viability of the cells. In a previous work, Wang et al. [29] studied the uptake of multiwalled carbon nanotubes (CNT) by immature dendritic cells (iDCs) and found that the incorporation of CNTs did not induce phenotypical changes in iDCs and did not affect the normal activation by lipopolysaccharides. Polystyrene particles have also been widely used for this purpose because they are commercially available with different fluorescent markers, surface charges and well-defined sizes
(from a few nanometres to a few microns). [30] The use of these types of particles has demonstrated that the cytotoxic effects depend on both the size and surface charge. [30, 31] The potential of biodegradable nanoparticles for antigen delivery using DCs has been demonstrated in vivo by Matsuo et al. [32] , who reported the inhibition of tumour growth in C57BL/6 mouse experiments. 
TEM study of internalisation
Optimisation of the uptake of MNPs by the DCs was required before these cells could be used as carriers to the tumoural vasculature. [33] This, in turn, required the determination of the uptake mechanisms involved for a given type of particle and cell line because these mechanisms would determine the uptake kinetics and intracellular fate of the nanoparticles. Endocytosis has been recognised as the most common passive mechanism for the MNP uptake by different cellular types, including HeLa cells, fibroblasts and DCs. The intracellular localisation of the MNPs was evaluated by TEM images of DCs cultured with MNPs during a 24-h period. In Figure   7 , a series of representative TEM images illustrated that the uptake sequence in DCs was a stepwise process in which the MNPs were first attached to the cell surface and subsequently internalised by vesicle-mediated endocytosis. After attaching to the external side of the cell (Figure 7a) , the invagination of the cell membrane began at the areas of contact (the arrow in Figure 7b ) to form an endosomal structure that finally progressed to the cell interior with most of its volume occupied by the endocytosed MNPs (Figure 7c-d) . Although the different stages of the uptake process were present in all samples observed, the fraction of mature endosomes was predominant.
The above results were in agreement with previously reported data [34] showing that monocyte-derived DCs were able to incorporate Fe@C magnetic nanoparticles and that the intracellular distribution of these MNPs was primarily located in the cytoplasmatic compartments. Several studies have also reported the uptake of different complexes, such as latex-type nanospheres, by DCs [35, 36] and the capacity of DCs to incorporate a wide range of antigens and molecules [37, 38] . In many cell lines, the uptake of MNPs occurs in a concentration-and time-dependent manner [39] that depends on some specific features of the MNPs involved. In the absence of surface functionalisation of MNPs with specific biologic ligands, as in the case of the present MNPs, the most probable mechanism involved in MNP uptake is nonspecific endocytosis.
Quantification of uploaded MNPs
Magnetic measurements of the MNP-loaded DCs were performed as a simple way of quantifying the amounts of magnetic material incorporated. Figure 8 shows the To study the physical state of aggregation of the MNPs in the intracellular space, the magnetic state of the MNPs at room temperature was analysed in samples of DCs+MNPs that were previously lyophilised. Similar to the pure colloids at room temperature (Figure 4 ), the particles uploaded by the cells displayed SPM behaviour reflected in the M(H) curves with null coercivity at 250 K (upper inset of Figure 8 ).
The magnetisation of such particles in the SPM state is described by the expression
M=M S L(x), where M S is the saturation magnetisation and L(x) is the Langevin
function with x=µH/k B T, µ is the magnetic moment of a single MNP, H is the applied field, k B is the Boltzmann constant and T is the temperature. To take the volume distribution into account, the SPM magnetisation of the particles was better described as a weighted sum of Langevin functions [22] .
where f(V) represents the distribution function of the particle volume, which is usually assumed as a log-normal function. It should be noted here that this expression assumes that the system is composed of noninteracting particles. The fit of the M(H) curves at room temperature using Eq. (1) for a) as-prepared ferrofluid and b) magnetically loaded DCs resulted in identical fitted parameters within error, as shown by the scaling of the corresponding M(H) curves in the upper inset of Figure 8 . This result indicates that a) the Fe 3 O 4 phase was not reduced/oxidised in the intracellular medium and that b) the particle size distribution remained essentially unaltered after the incorporation into the DCs (i.e., no selective sizes were incorporated). As discussed previously, the TEM images showed that MNPs were agglomerated inside the endosomal spaces [34] ; therefore, it was concluded that the dextran/functionalised shell was sufficiently thick to prevent strong interparticle interactions. This is an important issue for heating experiments in vitro because strongly interacting MNPs could result in a decrease of the power absorption. [40] 
Power absorption experiments
Once the incorporation of MNPs was verified and the cytotoxicity was evaluated, the effects of AMF were studied in MNP-loaded DCs. The heating efficiency of the magnetic colloids was measured through the absorbed power P divided by the mass m NP of the constituent nanoparticles diluted in a mass m LIQ of the liquid carrier. The expression for the SPA can be written as follows [6] :
where c LIQ and c NP are the specific heat capacities of the liquid carrier. Because the concentrations of MNPs are usually in the range of 1 % wt., we can approximate [21] m LIQ c LIQ + m NP c NP ≈ m LIQ c LIQ and (2) can be written as follows:
where δ LIQ and φ are the density of the liquid and the weight concentration of the MNPs in the colloid, respectively. The conversion from magnetic field energy into heat by the absorbing elements (i.e., the magnetic nanoparticles) at the frequencies of the experiment was due to the Néel relaxation process. Many recent reports have shown the details of this mechanism, which involves heat transference from nanoscopic agents (MNPs) to the macroscopic scale of the colloid. The common finding is that there is a strong dependence of SPA on particle size, with a narrow peak of absorption near the single-to multi-domain transition. [41, 42] As this represents a heat transference mechanism, an adiabatic experiment was needed to obtain actual SPA values for the given material by measuring the exact energy released as the temperature increased within the sample. Because the heating of a macroscopic amount of the sample took 10 2 to 10 3 seconds, high insulation was needed to provide adiabatic conditions during the whole experiment. Complete insulation is seldom attained in hyperthermia experiments [43] , as can be inferred from the measurable decrease of the temperature when the field was turned off. This condition hindered the accurate determination of the final temperature that could be attained with a given set of nanoparticles. However, the criterion for choosing a representative SPA value was related to the maximum slope of the T vs. time curves, which occurred during the first seconds of the experiments; thus, it can be ensured that the system behaved adiabatically because the amount of heat lost during this short interval could be neglected. Conversely, in vitro and in vivo power-absorption experiments were performed under strong heat-exchanging conditions, and therefore, it was neither possible nor interesting to quantify the power absorbed by the MNPs or the cells.
Although the measured parameter in the hyperthermia experiments was the temperature increase of the cell culture, the resulting cellular damage had to be related to the actual intracellular temperatures attained. However, to the best of our knowledge, there are no detailed studies on the dynamics of heat conduction from the intracellular medium through the cell membrane. In addition, the release of the power absorbed by the MNPs did not yield a macroscopic temperature increase when the temperature was measured in the whole culture medium by a macroscopic probe. The possibility remains, however, that the temperature of the intracellular medium increased during the AMF application, resulting in metabolic and/or cytoskeleton damage. This hypothesis must be tested using a yet-undeveloped microscopic, intracellular temperature probe, and work along this direction is currently being performed. In spite of the experimental difficulty for measuring intracellular temperatures, some theoretical calculations were performed to evaluate the capability of the number of MNPs incorporated to release sufficient energy to damage the subcellular structure.
From the average particle diameter of the MNPs measured by the TEM images, the number of particles within a single cell was estimated to be ≈1x10 4 . Assuming the same power absorption as the pure ferrofluid (36-46 W/g, see Table I ), this amount of MNPs could release a total power of ≈2x10 -10 W to the nearest organelles. If a short release time of 10 s was considered, the total energy available for local damage could be on the order of 1x10 10 eV. Compared to typical binding energies per atom in organic molecules (E C-N =308 eV, E C-C =348 eV, E C=C =614 eV), the previous estimation indicates that there should be sufficient energy available to induce bond breakage in the organic structures surrounding the MNPs.
The confinement of these particles within endosomal structures (as observed from the TEM images) drastically reduced their contact with intracellular structures.
Therefore, it seems plausible that the MNPs agglomerates observed inside the endosomes would be able to disrupt the endosomic membrane during AMF application. Endosomes and lysosomes are acidic vesicles involved in the endocytic pathway, and the lysosomes are the terminal degradation compartment of the phagocytosed material. Thus, the consequences of the local damage to the lysosomal membrane (i.e., the release of the lysosomal content into the cytoplasm) could induce changes in the intracellular medium that could lead to cell death.
Although a complete analysis of the actual mechanism at the cellular level would require a study of a variety of markers, such as proteases, caspases, and cytokines, the large fraction of dead cells observed in such a short time suggests that a necrosis-like process was the main cause of cell death during magnetic field application. The precise nature of this mechanism is of crucial importance for future application protocols because necrosis must always be avoided in vivo due to the lethal consequences to the surrounding tissues. If the energy release is the cause of cellular damage, the application time and power could be regulated to a value at which only apoptosis is triggered.
The combined results of a) low cytotoxicity of the magnetic MNPs and b) cell death after the application of an AMF suggest that MNP-loaded DCs could be used as magnetic carriers to tumoural regions, where cellular death induced by an external magnetic field could be used as a therapy against tumour growth.
Conclusions
Based on the described ability of DCs to be loaded with magnetic nanoparticles, they appear to be a potentially powerful 'Trojan horse' system for MNP delivery to specifically targeted sites. The results indicate that the MNPs had negligible cytotoxic effects and that the functionality of the DCs was maintained, which supports the feasibility of this approach. Therefore, the demonstration of AMF- The other authors declare that they do not have any affiliations that would lead to a conflict of interest.
